The estimated Net Worth of Yue Alexander Wu is at least $301 Tisíc dollars as of 3 February 2017. Yue Wu owns over 5,000 units of Sorrento Therapeutics Inc stock worth over $50 and over the last 8 years he sold SRNE stock worth over $0. In addition, he makes $301,400 as Independent Director at Sorrento Therapeutics Inc.
Yue has made over 1 trades of the Sorrento Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of SRNE stock worth $25,750 on 3 February 2017.
The largest trade he's ever made was buying 5,000 units of Sorrento Therapeutics Inc stock on 3 February 2017 worth over $25,750. On average, Yue trades about 500 units every 0 days since 2017. As of 3 February 2017 he still owns at least 5,000 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Yue Wu stock trades at the bottom of the page.
Dr. Yue Wu Ph.D. serves as Independent Director of the Company. Dr. Wu is currently an advisor to Crown Bioscience International. He was previously President, Chief Executive Officer and Chief Scientific Officer of Crown Bioscience International, a leading global drug discovery and development solutions company, which he co-founded in 2006, until 2017. From 2004 to 2006, Dr. Wu was Chief Business Officer of Starvax International Inc. in Beijing, China, a biotechnology company focusing on oncology and infectious diseases. From 2001 to 2004, Dr. Wu was a banker with Burrill & Company where he was head of Asian Activities. Dr. Wu has served as a director of CASI Pharmaceuticals, Inc. since June 2013. Dr. Wu received his Ph.D. in Molecular Cell Biology and his MBA from University of California at Berkeley. He earned an M.S. in Biochemistry from University of Illinois, Urbana-Champaign and his B.S. in Biochemistry from Fudan University in Shanghai, China.
As the Independent Director of Sorrento Therapeutics Inc, the total compensation of Yue Wu at Sorrento Therapeutics Inc is $301,400. There are 5 executives at Sorrento Therapeutics Inc getting paid more, with Jaisim Shah having the highest compensation of $10,971,100.
Yue Wu is 56, he's been the Independent Director of Sorrento Therapeutics Inc since 2017. There are 7 older and 4 younger executives at Sorrento Therapeutics Inc. The oldest executive at Sorrento Therapeutics Inc is Dr. Michael A. Royal, 67, who is the SVP & Chief Medical Officer.
Yue's mailing address filed with the SEC is CASI PHARMACEUTICALS, INC., 9620 MEDICAL CENTER DR. SUITE 300, ROCKVILLE, MD, 20850.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee a Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: